JACQUELINE WENTZ: Open Payments
NPI 1841668894 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 13 payments from 7 companies in 2025. Trend: 2023 $64 · 2024 $132 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| ABBVIE INC. | 3 | $50 |
| PFIZER INC. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: AIRSUPRA, AUSTEDO XR, QULIPTA, REXULTI, NURTEC ODT, Ozempic, Symbravo, UBRELVY.
Industry payments across IN — which companies pay providers there.
